More on ITMN
Data
Financials
News
Click line-items for a historical chart and %
| Actimmune | |
| Collaboration revenue | |
| Total revenue, net | 35.74M |
| Cost of goods sold | 5.77M |
| Research and development | 39.75M |
| General and administrative | |
| Restructuring charges | |
| Total costs and expenses | 98.15M |
| Loss from operations | -62.41M |
| Interest income | 266K |
| Interest expense | -3.9M |
| Other income (expense) | -382K |
| Net loss | -71.19M |
| Net loss per share | -0.72 |
| Shares used in computing basic and diluted net loss per share | |
Entities mentioned with ITMN
- Earnings | View Related Stories »
- Definitive Agreement | View Related Stories »
- UBS | View Related Stories »
- Citi | View Related Stories »
- Wells Fargo | View Related Stories »
- JPMorgan | View Related Stories »
- Robert W Baird | View Related Stories »
- Show More...
